ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Machine Learning and Radiogenomics: Lessons Learned and Future Directions

Kang, John*; Rancati, Tiziana; Lee, Sangkyu; Oh, Jung Hun; Kerns, Sarah L.; Scott, Jacob G.; Schwartz, Russell; Kim, Seyoung; Rosenstein, Barry S.
Frontiers in Oncology2018-6-21DOI: 10.3389/fonc.2018.00228
43被引1阅读
引用收藏
分享

摘要

Due to the rapid increase in the availability of patient data, there is significant interest in precision medicine that could facilitate the development of a personalized treatment plan for each patient on an individual basis. Radiation oncology is particularly suited for predictive machine learning (ML) models due to the enormous amount of diagnostic data used as input and therapeutic data generated as output. An emerging field in precision radiation oncology that can take advantage of ML approaches is radiogenomics, which is the study of the impact of genomic variations on the sensitivity of normal and tumor tissue to radiation. Currently, patients undergoing radiotherapy are treated using uniform dose constraints specific to the tumor and surrounding normal tissues. This is suboptimal in many ways. First, the dose that can be delivered to the target volume may be insufficient for control but is constrained by the surrounding normal tissue, as dose escalation can lead to significant morbidity and rare. Second, two patients with nearly identical dose distributions can have substantially different acute and late toxicities, resulting in lengthy treatment breaks and suboptimal control, or chronic morbidities leading to poor quality of life. Despite significant advances in radiogenomics, the magnitude of the genetic contribution to radiation response far exceeds our current understanding of individual risk variants. In the field of genomics, ML methods are being used to extract harder-to-detect knowledge, but these methods have yet to fully penetrate radiogenomics. Hence, the goal of this publication is to provide an overview of ML as it applies to radiogenomics. We begin with a brief history of radiogenomics and its relationship to precision medicine. We then introduce ML and compare it to statistical hypothesis testing to reflect on shared lessons and to avoid common pitfalls. Current ML approaches to genome-wide association studies are examined. The application of ML specifically to radiogenomics is next presented. We end with important lessons for the proper integration of ML into radiogenomics.

学科与关键词

关键词
statistical genetics and genomicsradiation oncologycomputational genomicsprecision oncologymachine learning in radiation oncologybig datapredictive modeling
相关
加载中…
  • Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making
    Deasy, Joseph O.*Seminars in Radiation Oncology, 2024, 34(4): 379-394.被引 1
  • Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine
    Saxena, Sanjay; Jena, Biswajit; Gupta, Neha; Das, Suchismita; Sarmah, Deepaneeta; Bhattacharya, Pallab; Nath, Tanmay; Paul, Sudip; Fouda, Mostafa M.; Kalra, Manudeep; Saba, Luca; Pareek, Gyan; Suri, Jasjit S.*Cancers, 2022, 14(12): 2860.被引 44
  • Towards a safe and efficient clinical implementation of machine learning in radiation oncology by exploring model interpretability, explainability and data-model dependency
    Barragan-Montero, Ana; Bibal, Adrien; Dastarac, Margerie Huet; Draguet, Camille; Valdes, Gilmer; Nguyen, Dan; Willems, Siri; Vandewinckele, Liesbeth; Holmstrom, Mats; Lofman, Fredrik; Souris, Kevin; Sterpin, Edmond; Lee, John A.Physics in Medicine and Biology, 2022, 67(11): 11TR01.被引 30
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2018-06-21
卷期
第 8 卷
页码
228
DOI
10.3389/fonc.2018.00228
期刊等级
Q2
成果收录
SCIE
资助标注
U.S. National Institutes of Health [R21CA216452]; Pennsylvania Department of Health Grant [GBMF4554, 4100070287]; Associazione Italiana Ricerca sul Cancro [AIRC-IG16087]; National Institutes of Health/National Cancer Institute Cancer Center Support Grant [P30 CA008748]; NIH [1R01CA134444, HHSN261201500043C, HHSN261201700033C]; American Cancer Society [RSGT-05-200-01-CCE]; Department of Defense Prostate Cancer Research Program [PC074201, PC140371]; NIH/NCI [1K07CA187546]; NSF CAREER Award [MCB-1149885]

作者

  • K

    Kang, John (通讯) (第一作者)

  • R

    Rancati, Tiziana

查看全部 9 位作者收起作者
  • L

    Lee, Sangkyu

  • O

    Oh, Jung Hun

  • K

    Kerns, Sarah L.

  • S

    Scott, Jacob G.

  • S

    Schwartz, Russell

  • K

    Kim, Seyoung

  • R

    Rosenstein, Barry S.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417